Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs

Hemophilia Growth and Development Study

Research output: Contribution to journalArticle

121 Citations (Scopus)

Abstract

Hepatitis C virus (HCV) and human immunodeficiency virus type 1 (HIV-1) coinfection is common in hemophiliacs and injection drug users. To assess the interaction between HCV load and HIV-1 disease progression, we examined 207 HIV-1/HCV-coinfected patients. Patients were followed prospectively for ∼7 years, and annual measurements of CD4+ cell counts and HCV and HIV-1 loads were obtained. Survival analysis was used to define the independent effects of HCV load on HIV-1 progression. After controlling for CD4+ cell count and HIV-1 RNA level, every 10-fold increase in baseline HCV RNA was associated with a relative risk (RR) for clinical progression to acquired immunodeficiency syndrome (AIDS) of 1.66 (95% confidence interval [CI], 1.10-2.51; P = .016) and an RR for AIDS-related mortality of 1.54 (95% CI, 1.03-2.30; P = .036). These findings emphasize the need for further research regarding the use of HIV-1- and HCV-specific therapy in coinfected individuals.

Original languageEnglish (US)
Pages (from-to)589-595
Number of pages7
JournalJournal of Infectious Diseases
Volume183
Issue number4
DOIs
StatePublished - Feb 15 2001

Fingerprint

Virus Diseases
Hepacivirus
Disease Progression
HIV-1
CD4 Lymphocyte Count
Acquired Immunodeficiency Syndrome
RNA
Confidence Intervals
Survival Analysis
Drug Users
Coinfection
Injections
Mortality
Research

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Cite this

Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs. / Hemophilia Growth and Development Study.

In: Journal of Infectious Diseases, Vol. 183, No. 4, 15.02.2001, p. 589-595.

Research output: Contribution to journalArticle

@article{fe75e75ba4b94027a32b46d35923c99c,
title = "Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs",
abstract = "Hepatitis C virus (HCV) and human immunodeficiency virus type 1 (HIV-1) coinfection is common in hemophiliacs and injection drug users. To assess the interaction between HCV load and HIV-1 disease progression, we examined 207 HIV-1/HCV-coinfected patients. Patients were followed prospectively for ∼7 years, and annual measurements of CD4+ cell counts and HCV and HIV-1 loads were obtained. Survival analysis was used to define the independent effects of HCV load on HIV-1 progression. After controlling for CD4+ cell count and HIV-1 RNA level, every 10-fold increase in baseline HCV RNA was associated with a relative risk (RR) for clinical progression to acquired immunodeficiency syndrome (AIDS) of 1.66 (95{\%} confidence interval [CI], 1.10-2.51; P = .016) and an RR for AIDS-related mortality of 1.54 (95{\%} CI, 1.03-2.30; P = .036). These findings emphasize the need for further research regarding the use of HIV-1- and HCV-specific therapy in coinfected individuals.",
author = "{Hemophilia Growth and Development Study} and Daar, {Eric S.} and Henry Lynn and Sharyne Donfield and Edward Gomperts and O’brien, {Stephen J.} and Hilgartner, {Margaret W.} and Hoots, {W. Keith} and David Chernoff and Steven Arkin and Wong, {W. Y.} and Winkler, {Cheryl A.} and E. Gomperts and Wong, {W. Y.} and F. Kaufman and M. Nelson and S. Pearson and M. Hilgartner and S. Cunningham-Rundles and I. Goldberg and Hoots, {W. K.} and K. Loveland and M. Cantini and A. Willoughby and S. McKinlay and S. Donfield and C. Contant and Kisker, {C. T.} and J. Stehbens and S. O’conner and J. McKillip and P. Sirois and C. Sexauer and H. Huszti and F. Kiplinger and S. Hawk and S. Arkin and A. Forster and S. Swindells and S. Richard and J. Mangos and A. Scott and R. Davis and J. Lusher and I. Warrier and K. Baird-Cox and Eyster, {M. E.} and D. Ungar and S. Neagley and A. Shapiro and J. Morris",
year = "2001",
month = "2",
day = "15",
doi = "10.1086/318539",
language = "English (US)",
volume = "183",
pages = "589--595",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs

AU - Hemophilia Growth and Development Study

AU - Daar, Eric S.

AU - Lynn, Henry

AU - Donfield, Sharyne

AU - Gomperts, Edward

AU - O’brien, Stephen J.

AU - Hilgartner, Margaret W.

AU - Hoots, W. Keith

AU - Chernoff, David

AU - Arkin, Steven

AU - Wong, W. Y.

AU - Winkler, Cheryl A.

AU - Gomperts, E.

AU - Wong, W. Y.

AU - Kaufman, F.

AU - Nelson, M.

AU - Pearson, S.

AU - Hilgartner, M.

AU - Cunningham-Rundles, S.

AU - Goldberg, I.

AU - Hoots, W. K.

AU - Loveland, K.

AU - Cantini, M.

AU - Willoughby, A.

AU - McKinlay, S.

AU - Donfield, S.

AU - Contant, C.

AU - Kisker, C. T.

AU - Stehbens, J.

AU - O’conner, S.

AU - McKillip, J.

AU - Sirois, P.

AU - Sexauer, C.

AU - Huszti, H.

AU - Kiplinger, F.

AU - Hawk, S.

AU - Arkin, S.

AU - Forster, A.

AU - Swindells, S.

AU - Richard, S.

AU - Mangos, J.

AU - Scott, A.

AU - Davis, R.

AU - Lusher, J.

AU - Warrier, I.

AU - Baird-Cox, K.

AU - Eyster, M. E.

AU - Ungar, D.

AU - Neagley, S.

AU - Shapiro, A.

AU - Morris, J.

PY - 2001/2/15

Y1 - 2001/2/15

N2 - Hepatitis C virus (HCV) and human immunodeficiency virus type 1 (HIV-1) coinfection is common in hemophiliacs and injection drug users. To assess the interaction between HCV load and HIV-1 disease progression, we examined 207 HIV-1/HCV-coinfected patients. Patients were followed prospectively for ∼7 years, and annual measurements of CD4+ cell counts and HCV and HIV-1 loads were obtained. Survival analysis was used to define the independent effects of HCV load on HIV-1 progression. After controlling for CD4+ cell count and HIV-1 RNA level, every 10-fold increase in baseline HCV RNA was associated with a relative risk (RR) for clinical progression to acquired immunodeficiency syndrome (AIDS) of 1.66 (95% confidence interval [CI], 1.10-2.51; P = .016) and an RR for AIDS-related mortality of 1.54 (95% CI, 1.03-2.30; P = .036). These findings emphasize the need for further research regarding the use of HIV-1- and HCV-specific therapy in coinfected individuals.

AB - Hepatitis C virus (HCV) and human immunodeficiency virus type 1 (HIV-1) coinfection is common in hemophiliacs and injection drug users. To assess the interaction between HCV load and HIV-1 disease progression, we examined 207 HIV-1/HCV-coinfected patients. Patients were followed prospectively for ∼7 years, and annual measurements of CD4+ cell counts and HCV and HIV-1 loads were obtained. Survival analysis was used to define the independent effects of HCV load on HIV-1 progression. After controlling for CD4+ cell count and HIV-1 RNA level, every 10-fold increase in baseline HCV RNA was associated with a relative risk (RR) for clinical progression to acquired immunodeficiency syndrome (AIDS) of 1.66 (95% confidence interval [CI], 1.10-2.51; P = .016) and an RR for AIDS-related mortality of 1.54 (95% CI, 1.03-2.30; P = .036). These findings emphasize the need for further research regarding the use of HIV-1- and HCV-specific therapy in coinfected individuals.

UR - http://www.scopus.com/inward/record.url?scp=0035865910&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035865910&partnerID=8YFLogxK

U2 - 10.1086/318539

DO - 10.1086/318539

M3 - Article

C2 - 11170984

AN - SCOPUS:0035865910

VL - 183

SP - 589

EP - 595

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 4

ER -